Serum Institute of India (SII) seeks nod from government to export Covovax to US

According to a communication sent to the government by Prakash Kumar Singh, the Director of Government and Regulatory Affairs at the SII, the shipment is likely to be dispatched on July 3

Serum Institute of India (SII) seeks nod from government to export Covovax to US
Photo by Hakan Nural / Unsplash

The Serum Institute of India(SII) has sought for the Union Government’s approval to export 3.2 million doses of Covovax under the brand name Nuvaxovid to the US.

SII manufactures Covovax- the second corona virus vaccine after Covishield by the company, under a license from the vaccine’s developer, US-based Novavax. The export version of the vaccine is called Nuvaxovid, which has also been dispatched by the Pune-based vaccine maker to New Zealand, Netherlands, Australia and Indonesia, where about 100 million doses have been sent.